Curaleaf Holdings (CURLF) EPS (Basic) (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 97.24% year-on-year from -$0.0 in Q1 2025, and up 98.16% on a QoQ basis from -$0.02 in Q4 2025.
Curaleaf Holdings (CURLF) EPS (Basic) (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported EPS (Basic) for 8 consecutive years, with -$0.0 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 97.24% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.03 (up 4.24% YoY) and the FY2025 annual result came in at -$0.03, down 145.41% from the prior year.
- EPS (Basic) grew to -$0.0 in Q1 2026 per CURLF's latest filing, from -$0.02 in the prior quarter.
- Over the last five years, EPS (Basic) for CURLF reached as high as $0.09 in Q1 2022 and fell as low as -$11.04 in Q4 2023.
- A 5-year average of -$0.66 and a median of -$0.01 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 8991.47% — and 2024, when it surged 106.11%.
- Year by year, EPS (Basic) stood at -$0.12 in 2022, then slumped by 8991.47% to -$11.04 in 2023, then soared by 99.86% to -$0.02 in 2024, then plunged by 34.6% to -$0.02 in 2025, then soared by 98.16% to -$0.0 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.02, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -11.04 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.11 |